The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Olympus Biotech Corporation
ClinicalTrials.gov Identifier:
NCT01217463
First received: October 7, 2010
Last updated: April 22, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)